Skip to main content
. 2020 Jan 25;21(4):557–572. doi: 10.1007/s10198-020-01159-y

Table 2.

Costs and utilities

Distribution Source
Intervention costs
SAVR 25,474 Multivariate normal4 [4]*
TAVI 33,178 Multivariate normal4 [4]*
Event treatment costs
Stroke 3054 Multivariate normal4 [4]*
Myocardial infarction 5157 Multivariate normal4 [4]*
Vascular complications 5112 Uniform (∓ 20%) [48]
Reexploration for bleeding 5048 Uniform (∓ 20%) [48]
Bleeding 1617 Uniform (∓ 20%) [48]
Atrial fibrillation (without PI) 1225 Multivariate normal4 [4]*
Pacemaker implantation (PI) 11,738 Multivariate normal4 [4]*
Acute kidney injury/renal failure 9650 Multivariate normal4 [4]*
Prosthetic valve dysfunction 1478 Uniform (∓ 20%) [4954]
Prosthetic valve thrombosis 5824 Uniform (∓ 20%) [5355]
Prosthetic valve endocarditis 8923 Multivariate normal4 [4]*
Re-intervention SAVR 25,936 Multivariate normal4 [4]*
Re-intervention TAVI 33,178 Multivariate normal4 [4]*
Other healthcare cost1
Post-intervention year 1 18,479 Multivariate normal4 [4]*
Post-intervention year 2 10,607 [4]*
Post-intervention year 3 10,832 [4]*
Productivity costs of unpaid work3 Costs per month
SAVR 44 Multivariate normal4 [23]
TAVI 50 Multivariate normal4 [23]
Informal care costs3 Costs per month
SAVR 164 Multivariate normal4 [23]
TAVI 388 Multivariate normal4 [23]
Utilities at start of the simulation
SAVR 0.837 Multivariate normal4 [23]
TAVI 0.718 Multivariate normal4 [23]
Utilities after events Utility multiplier Duration
Stroke 0.841 Lifetime Uniform5 [56, 57]
Myocardial infarction 0.914 1 year Uniform5 [58, 59]
Vascular complications 0.981 1 week Uniform5 [60]
Bleeding 0.965 1 year Uniform5 [61]
Atrial fibrillation (without PI) 0.955 1 year Uniform5 [62]
Pacemaker implantation (PI) 0.804 1 month Uniform5 [63]
Acute kidney injury/renal failure 0.804 1 year Uniform5 [64]
Re-intervention 0.946

SAVR/TAVI:

4/1 month(s)

Uniform5 [65]/[8]
Conservative treatment of:
 Prosthetic valve dysfunction 0.8862 Lifetime Uniform5 [50, 66]
 Prosthetic valve thrombosis 0.9682 10 days Uniform5 [55, 67]
 Prosthetic valve endocarditis 0.9682 6 weeks Uniform5 [67, 68]

*Mean in the Vektis database adjusted to 2016€. Costs in the model dependent on patient and intervention characteristics using (M)GLM [4]

1Mean total healthcare costs per year including costs of treatment of events and death (costs types are estimated separately in the model), but excluding intervention costs. Costs are based on data of SAVR patients, but it is assumed they are also applicable to TAVI patients

2Conservative treatment, no re-intervention

3Mean across all patients, including patients without unpaid work or informal care

4Multivariate normal distribution: coefficients of the regression model are randomly drawn from a multivariate normal distribution based on coefficients and variance–covariance matrix

550% deviation of 1-utility multiplier to prevent the utility multiplier from exceeding 1